Abstract
Purpose
Antimicrobial use (AMU) is estimated at the national level by using sales data (S-AMU) or insurance claims data (C-AMU). However, these data might be biased by generic drugs that are not sold through wholesalers (direct sales) and therefore not recorded in sales databases, or by claims that are not submitted electronically and therefore not stored in claims databases. We evaluated these effects by comparing S-AMU and C-AMU to ascertain the characteristics and limitations of each kind of data. We also evaluated the interchangeability of these data by assessing their relationship.
Methods
We calculated monthly defined daily doses per 1,000 inhabitants per day (DID) using sales and claims data from 2013 to 2017. To assess the effects of non-electronic claim submissions on C-AMU, we evaluated trends in the S-AMU/C-AMU ratio (SCR). To assess the effects of direct sales of S-AMU, we divided AMU into generic and branded drugs and evaluated each SCR in terms of oral versus parenteral drugs. To assess the relationship between S-AMU and C-AMU, we created a linear regression and evaluated its coefficient.
Results
Median annual SCRs from 2013 to 2017 were 1.046, 0.993, 0.980, 0.987, and 0.967, respectively. SCRs dropped from 2013 to 2015, and then stabilized. Differences in SCRs between branded and generic drugs were significant for oral drugs (0.820 vs 1.079) but not parenteral drugs (1.200 vs 1.165), suggesting that direct sales of oral generic drugs were omitted in S-AMU. Coefficients of DID between S-AMU and C-AMU were high (generic, 0.90; branded, 0.84) in oral drugs but relatively low (generic, 0.32; branded, 0.52) in parenteral drugs.
Conclusions
The omission of direct sales information and non-electronically submitted claims have influenced S-AMU and C-AMU information, respectively. However, these data were well-correlated, and it is considered that both kinds of data are useful depending on the situation.
Funder
Ministry of Health, Labour and Welfare
Publisher
Public Library of Science (PLoS)
Reference21 articles.
1. World Health Organization. Global action plan on antimicrobial resistance. [Cited 2020 Mar 12] Available from: https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1
2. World Health Organization. Surveillance of Antimicrobial Use. [cited 2021 Mar 4]. Available from: http://www.who.int/medicines/areas/rational_use/AMU_Surveillance/en/
3. How Can We Routinely Measure Appropriateness of Antimicrobial Use in Hospitals at a National Level?;C Pulcini;JAMA Netw Open,2019
4. Antibiotic Consumption Increasing Globally;M Friedrich;JAMA,2018
5. Estimating global trends in total and childhood antibiotic consumption, 2011–2015;C Jackson;BMJ Glob Health,2019